Cognetivity Neurosciences (CGN.C) is a technology company that has developed a cognitive testing platform for use in medical, commercial, and consumer environments. Dubbed the Integrated Cognitive Assessment (ICA) tool,…
CGN.C
Cognetivity Neuroscience (CGN.C) announced today that it has finalized a commercial agreement with Birmingham and Solihull Mental Health NHS Foundation Trust (BSMHFT) to deploy its Integrated Cognitive Assessment (ICA)…
Cognetivity Neurosciences (CGN.C) announced today that its Integrated Cognitive Assessment (ICA) will become an integral part of a new and highly innovative clinic in the UK’s Nation Health Service…
Cognetivity Neurosciences (CGN.C) announced today that its Integrated Cognitive Assessment (ICA) will become an integral part of a new and highly innovative clinic in the UK’s Nation Health Service…
Cognetivity Neurosciences (CGN.C) announced today that its Integrated Cognitive Assessment (ICA) will become an integral part of a new and highly innovative clinic in the UK’s Nation Health Service…
Cognetivity Neurosciences (CGN.C) today announced the publication of the latest scientific paper on its Integrated Cognitive Assessment (ICA) in the peer-reviewed academic journal, Frontiers in Psychiatry. “Empowered by AI,…
Cognetivity Neurosciences (CGN.C) announced today that it has launched in Dubai, United Arab Emirates (UAE), marking the Company’s first expansion into the Middle East. “We’re enormously excited about this…
Cognetivity Neurosciences’ (CGN.C) latest scientific publication touts their Integrated Cognitive Assessment (ICA) tool as a weapon for detecting and monitoring cognitive impairment associated with neurodegenerative diseases. The ICA’s original…
Cognetivity Neurosciences (CGN.C) has reached the threshold of participants in their clinical evaluation study of its integrated cognitive assessment (ICA) platform for dementia sufferers to register for CE marking….